What is the recommended treatment regimen for uncomplicated gonorrhea, including options for pregnant patients, those with severe beta‑lactam allergy, and breastfeeding mothers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Uncomplicated Gonorrhea

For uncomplicated gonorrhea, treat with ceftriaxone 125 mg IM as a single dose, plus treatment for chlamydia (azithromycin 1 g orally or doxycycline 100 mg twice daily for 7 days) if chlamydial coinfection is not ruled out. 1, 2

Standard Treatment Regimen

The recommended first-line treatment consists of:

  • Ceftriaxone 125 mg IM in a single dose
  • PLUS (if chlamydia not excluded):
    • Azithromycin 1 g orally single dose, OR
    • Doxycycline 100 mg orally twice daily for 7 days

1, 2, 1

This regimen provides sustained bactericidal levels and cures >99% of uncomplicated urogenital and anorectal infections 1. Alternative oral options include ciprofloxacin 500 mg or ofloxacin 400 mg, though quinolone resistance is now widespread and these should only be used when local susceptibility patterns support their use 3.

Special Populations

Pregnant Patients

Pregnant women should receive ceftriaxone 125 mg IM plus azithromycin 1 g orally (or erythromycin/amoxicillin for chlamydia). 1

Key considerations:

  • Quinolones and tetracyclines are absolutely contraindicated in pregnancy 1, 2
  • Ceftriaxone and spectinomycin are safe and effective, with cure rates of 95% 4
  • Amoxicillin with probenecid has lower efficacy (89%) and is not recommended 4
  • For severe beta-lactam allergy: spectinomycin 2 g IM single dose 1

Severe Beta-Lactam Allergy

For patients who cannot tolerate cephalosporins, use spectinomycin 2 g IM as a single dose. 1, 5

Critical caveat: Spectinomycin is only 52% effective against pharyngeal infections 1, 2. If pharyngeal infection is suspected or confirmed, obtain a pharyngeal culture 3-5 days post-treatment to verify eradication 1.

Breastfeeding Mothers

Breastfeeding mothers can receive the standard ceftriaxone regimen. The guidelines specify that quinolones are contraindicated for nursing women 5, but ceftriaxone and azithromycin are safe during lactation.

Pharyngeal Gonorrhea

Pharyngeal infections are harder to eradicate and require specific regimens:

  • Ceftriaxone 125 mg IM, OR
  • Ciprofloxacin 500 mg orally (where susceptibility confirmed)

1

These are the only regimens reliably curing >90% of pharyngeal infections 2, 1. Avoid spectinomycin for pharyngeal disease due to poor efficacy.

Follow-Up and Partner Management

  • No test-of-cure needed for uncomplicated cases treated with recommended regimens 1, 2, 1
  • Persistent symptoms warrant culture with antimicrobial susceptibility testing 1
  • Treat all sexual partners from the past 60 days before symptom onset or diagnosis 1, 2
  • Patients should avoid intercourse until therapy is completed and both partners are symptom-free 1, 2

Common Pitfalls

  1. Failing to treat for chlamydia: 40% of gonorrhea patients have concurrent chlamydial infection 4. Always treat presumptively unless chlamydia is specifically ruled out.

  2. Using quinolones without considering resistance: Quinolone resistance is now widespread. The 2006 guidelines already restricted quinolone use for MSM and those with travel to high-resistance areas 3.

  3. Inadequate treatment in pregnancy: Never use quinolones or tetracyclines. Spectinomycin is the only safe alternative to cephalosporins 1.

  4. Ignoring pharyngeal infection: Most pharyngeal infections are asymptomatic but harder to treat. Consider pharyngeal testing in treatment failures 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.